Eptinezumab Reduced the Frequency of Migraine Days in Patients With Chronic Migraine and Medication-Overuse Headache: Subgroup Analysis of PROMISE-2

H. -C. Diener, M. Marmura,J. Hirman, L. Mehta,T. Brevig,E. Brunner,R. Cady

HEADACHE(2020)

引用 2|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要